Biotec Pharmacon ASA (BIOTEC):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Biotec Pharmacon ASA (BIOTEC) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6570
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biotec Pharmacon ASA (Biotec Pharmacon) is a biopharmaceutical company that develops, manufactures and markets immune modulating compounds and cold adapted enzymes. The company provides products which are used in the areas of human medicine such as immunotherapy of cancer, general infection prophylaxis and imbalanced immune responses, among others. It has developed M-Gard, an immunomodulator that enhances your body’s vital defence mechanisms against pathogens such as bacteria, virus, and fungus. Biotec Pharmacon carries out cellular or molecular level research on its proprietary beta-1,3 and 1,6-glucan products, a non-toxic modulator that improves immune resistance. The company operates through its subsidiaries in Tromso. Biotec Pharmacon is headquartered in Tromso, Norway.

Biotec Pharmacon ASA (BIOTEC) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biotec Pharmacon ASA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Biotec Pharmacon ASA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Biotec Pharmacon ASA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Biotec Pharmacon ASA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Biotec Pharmacon ASA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Biotec Pharmacon ASA, Medical Equipment, Deal Details 10
Equity Offering 10
Biotec Pharmacon Raises USD2.9 Million in Private Placement of Shares 10
Biotec Pharmacon Raises USD13.3 Million in Private Placement of Shares 11
Biotec Pharmacon Completes Rights Offering Of Shares For US$2 Million 12
Biotec Pharmacon Completes Private Placement Of Shares For US$7 Million 13
Biotec Pharmacon ASA – Key Competitors 14
Biotec Pharmacon ASA – Key Employees 15
Biotec Pharmacon ASA – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Apr 26, 2018: Biotec Pharmacon Reports Financial Results For Q1 2018 17
Jan 31, 2018: Biotec Pharmacon: Fourth quarter 2017 results 18
Oct 19, 2017: Biotec Pharmacon: Results for Q3 2017 19
Feb 02, 2017: Biotec Pharmacon: Results for Q4 2016 20
Corporate Communications 21
Sep 12, 2017: Biotec Pharmacon appoints new CEO 21
Sep 06, 2017: Biotec Pharmacon – resignation of board member 22
Legal and Regulatory 23
Jan 16, 2018: ISO 13485 Approvals in Biotec Pharmacon 23
Product News 24
Dec 20, 2017: ArcticZymes launches two new polymerase enzymes 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Biotec Pharmacon ASA, Medical Equipment, Key Facts, 2017 2
Biotec Pharmacon ASA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Biotec Pharmacon ASA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Biotec Pharmacon ASA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Biotec Pharmacon ASA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Biotec Pharmacon ASA, Deals By Market, 2012 to YTD 2018 8
Biotec Pharmacon ASA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Biotec Pharmacon Raises USD2.9 Million in Private Placement of Shares 10
Biotec Pharmacon Raises USD13.3 Million in Private Placement of Shares 11
Biotec Pharmacon Completes Rights Offering Of Shares For US$2 Million 12
Biotec Pharmacon Completes Private Placement Of Shares For US$7 Million 13
Biotec Pharmacon ASA, Key Competitors 14
Biotec Pharmacon ASA, Key Employees 15
Biotec Pharmacon ASA, Subsidiaries 16

List of Figures
Biotec Pharmacon ASA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Biotec Pharmacon ASA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Biotec Pharmacon ASA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Biotec Pharmacon ASA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Biotec Pharmacon ASA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Biotec Pharmacon ASA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Biotec Pharmacon ASA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Biotec Pharmacon ASA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Biotec Pharmacon ASA (BIOTEC):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kobayashi Pharmaceutical Co Ltd (4967)-医療機器分野:企業M&A・提携分析
    Summary Kobayashi Pharmaceutical Co Ltd (Kobayashi) is a manufacturer and distributor of pharmaceutical, health and personal care products. The company offers OTC pharmaceuticals, oral hygiene products, deodorizing air fresheners, cooling gel sheets, sanitary products, household sundries, and body w …
  • Energy Recovery Inc (ERII):企業の財務・戦略的SWOT分析
    Energy Recovery Inc (ERII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • HEICO Corporation:企業の戦略・SWOT・財務情報
    HEICO Corporation - Strategy, SWOT and Corporate Finance Report Summary HEICO Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Omnicell Inc (OMCL):企業の財務・戦略的SWOT分析
    Omnicell Inc (OMCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Masterflex SE (MZX):企業の財務・戦略的SWOT分析
    Summary Masterflex SE (Masterflex), formerly Masterflex AG, is a manufacturer and supplier of spiral hoses. The company manufactures and markets high-tech spiral hoses. It offers hoses and connecting systems such as abrasion-resistant suction and transport hoses made from PU, suction and transport h …
  • Ricoh Co Ltd (7752):企業の財務・戦略的SWOT分析
    Ricoh Co Ltd (7752) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • DISH Network Corp (DISH):企業の財務・戦略的SWOT分析
    DISH Network Corp (DISH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • China Singyes Solar Technologies Holdings Ltd (750):企業の財務・戦略的SWOT分析
    China Singyes Solar Technologies Holdings Ltd (750) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s ke …
  • Champions Oncology Inc (CSBR):製薬・医療:M&Aディール及び事業提携情報
    Summary Champions Oncology Inc (Champions), formerly Champions Biotechnology Inc, is a developer of advanced technology solutions and services to personalize the development and use of oncology drugs. The company’s technology platform is an approach based upon the implantation of primary human tumor …
  • JCR Pharmaceuticals Co Ltd (4552):製薬・医療:M&Aディール及び事業提携情報
    Summary JCR Pharmaceuticals Co Ltd (JCR) manufactures, sells, buys, imports and exports pharmaceutical products. It provides biopharmaceuticals in the field of regenerative medicine for the treatment of rare diseases. The company offers pharmaceuticals to treat growth hormone deficiency, turner synd …
  • Sberbank of Russia:企業のM&A・事業提携・投資動向
    Sberbank of Russia - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sberbank of Russia Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Anixter International Inc (AXE):電力:M&Aディール及び事業提携情報
    Summary Anixter International Inc. (Anixter), formerly Itel Corporation, is a distributor of network and security solutions, electrical and electronic solutions and utility power solutions. The company distributes communications, and electrical wire and cable products, fasteners and C Class inventor …
  • Mitochon Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Mitochon Pharmaceuticals Inc (Mitochon Pharma) is a biotechnology company that develops drugs for neurodegenerative and neuromuscular diseases. The company’s pipeline products include mitochondrial modulators such as MP-101, MP-201 and MP-301. It targets diseases such as batten disease, stro …
  • Hermes Europe GmbH:企業の戦略的SWOT分析
    Hermes Europe GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • DTEK Energy BV:企業の戦略的SWOT分析
    DTEK Energy BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • CanBas Co Ltd (4575):製薬・医療:M&Aディール及び事業提携情報
    Summary CanBas Co Ltd (CanBas) is a clinical stage biopharmaceutical company that develops therapeutics for cancer. The company discovers and develops of novel therapeutics in the field of oncology targeting the cell cycle. It provides two clinical oncology programs, CBP501 and CBS9106 with mutually …
  • Kancera AB (KAN):企業の財務・戦略的SWOT分析
    Summary Kancera AB (Kancera) is a developer of drug candidates for the treatment of cancer. The company’s pipeline products include fractalkine inhibitor AZD8797, used to stop tumor growth; small molecule HDAC6 inhibitors, for neutralizing blood cancer; small molecule PFKFB3 inhibitors, for stopping …
  • 3E sanv:企業の戦略的SWOT分析
    3E sanv - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Oriola-KD Oyj (OKDBV):企業の財務・戦略的SWOT分析
    Oriola-KD Oyj (OKDBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Kronos Worldwide Inc (KRO):企業の財務・戦略的SWOT分析
    Kronos Worldwide Inc (KRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆